Monthly Archives: April 2014

Distek Welcomes New Midwest Sales Representative

We are pleased to announce Distek’s New Technical Sales Representative for the Midwest Territory, Mr. Ronald Turn.

Ron is a graduate of Western Illinois University and brings to Distek extensive experience in a variety of analytical techniques and instrumentation.

Ron has worked for Akzo Nobel as a QA/QC chemist, as well as ProMedTek and LabLogic as a sales representative.

The states included in the realigned Midwest Territory include: Arizona, Arkansas, Colorado, Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, New Mexico, North Dakota, Ohio, Oklahoma, Pennsylvania (Zip Codes 15000 – 16899 only), South Dakota, Utah, and Wisconsin.

Midwest-Territory

Distek customers within this region should expect to be contacted by Ron in the near future.  In the meantime, should you have any questions or wish to discuss any of Distek’s products or services, please feel free to contact Ron directly.

Ron can be reached at (312) 835-1129 or by email at ronald.turn@distekinc.com.

Please join us in welcoming Ron to Distek.

Leave a comment

Filed under Employee Announcement

Distek’s sensIR 3200 “Bathless” Disintegrator with Auto Endpoint Detection is Now Available

North Brunswick, NJ – Distek, Inc., an industry leader in pharmaceutical laboratory testing instruments, accessories and validation services, is pleased to announce the availability of auto detection on the sensIR 3200 “Bathless” Disintegrator.

sensIR 3200The sensIR 3200 utilizes “Patent Pending” Near Infrared to monitor and determine the disintegration endpoint for solid dosages. This state-of-the-art technology provides endpoint detection without the need of a modified fluted disk, therefore eliminating the accelerated disintegration and disparity the use of a fluted disk can cause with monographs not requiring disks.

“Unattended endpoint detection saves time and increases throughput” says Jeff Seely, Vice President of Sales & Business Development. “The release of the sensIR 3200 is another example of Distek’s innovation and leadership in the pharmaceutical testing market space. The use of IR to detect the presence of the tablet is a leap forward in disintegration testing providing reliable results and compliance with all monographs.”

For additional information contact Distek’s Corporate Office at +1 732 422 7585, by email at info@distekinc.com or visit www.distekinc.com.

Leave a comment

Filed under sensIR 3200, Uncategorized